The discovery of GSK221149A: a potent and selective oxytocin antagonist.
Bioorg Med Chem Lett
; 18(1): 90-4, 2008 Jan 01.
Article
em En
| MEDLINE
| ID: mdl-18032036
ABSTRACT
Optimisation of a series of oxazole diketopiperazines has led to the discovery of a very potent and selective oxytocin antagonist GSK221149A. GSK221149A has been shown to inhibit oxytocin-induced uterine contractions in the anaesthetised rat.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Piperazinas
/
Ocitocina
Limite:
Animals
/
Female
/
Humans
Idioma:
En
Ano de publicação:
2008
Tipo de documento:
Article